BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 14604887)

  • 1. Susceptibility to vascular neoplasms but no increased susceptibility to renal carcinogenesis in Vhl knockout mice.
    Kleymenova E; Everitt JI; Pluta L; Portis M; Gnarra JR; Walker CL
    Carcinogenesis; 2004 Mar; 25(3):309-15. PubMed ID: 14604887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene.
    Ma W; Tessarollo L; Hong SB; Baba M; Southon E; Back TC; Spence S; Lobe CG; Sharma N; Maher GW; Pack S; Vortmeyer AO; Guo C; Zbar B; Schmidt LS
    Cancer Res; 2003 Sep; 63(17):5320-8. PubMed ID: 14500363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.
    Haase VH; Glickman JN; Socolovsky M; Jaenisch R
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1583-8. PubMed ID: 11171994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic expression of von Hippel-Lindau tumor suppressor induces apoptosis in 786-O renal cell carcinoma cells and regresses tumor growth of 786-O cells in nude mouse.
    Kim M; Yan Y; Lee K; Sgagias M; Cowan KH
    Biochem Biophys Res Commun; 2004 Jul; 320(3):945-50. PubMed ID: 15240140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location.
    Maranchie JK; Afonso A; Albert PS; Kalyandrug S; Phillips JL; Zhou S; Peterson J; Ghadimi BM; Hurley K; Riss J; Vasselli JR; Ried T; Zbar B; Choyke P; Walther MM; Klausner RD; Linehan WM
    Hum Mutat; 2004 Jan; 23(1):40-6. PubMed ID: 14695531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 is not inactivated in B6C3F1 mouse vascular tumors arising spontaneously or associated with long-term administration of the thiazolidinedione troglitazone.
    Duddy SK; Parker RF; Bleavins MR; Gough AW; Rowse PE; Gorospe S; Dethloff LA; de la Iglesia FA
    Toxicol Appl Pharmacol; 1999 Apr; 156(2):106-12. PubMed ID: 10198275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the tumor suppressor gene von Hippel-Lindau (VHL) in granulocytes contributes to development of liver hemangiomas in a mouse model.
    Bader HL; Hsu T
    BMC Cancer; 2016 Oct; 16(1):797. PubMed ID: 27733136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects respond to cerebral ischemia without susceptibility to HB-tumorigenesis in VHL heterozygous knockout mice.
    Wang Y; Yang J; Du G; Ma D; Zhou L
    Mol Carcinog; 2017 Oct; 56(10):2342-2351. PubMed ID: 28574654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency.
    Zanesi N; Mancini R; Sevignani C; Vecchione A; Kaou M; Valtieri M; Calin GA; Pekarsky Y; Gnarra JR; Croce CM; Huebner K
    Cancer Res; 2005 Aug; 65(15):6576-82. PubMed ID: 16061637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Susceptibility of wild and knockout p53 FVB/N line mice to benz(a)pyrene-induced subcutaneous sarcoma].
    Anikin IV; Kozlov AP; Popov AV; Zabezhinskiĭ MA; Tyndyk ML; Anisimov VN
    Vopr Onkol; 2002; 48(6):700-2. PubMed ID: 12530267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the spontaneous Tsc2 knockout (Eker) rat model of hereditary renal cell carcinoma for the study of renal carcinogens.
    McDorman KS; Wolf DC
    Toxicol Pathol; 2002; 30(6):675-80. PubMed ID: 12512868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p53 heterozygous knockout mouse as a model for chemical carcinogenesis in vascular tissue.
    Carmichael NG; Debruyne EL; Bigot-Lasserre D
    Environ Health Perspect; 2000 Jan; 108(1):61-5. PubMed ID: 10620525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary renal carcinogenesis fitting Knudson's two-hit model: genotype, environment, and phenotype.
    Hino O
    Genes Chromosomes Cancer; 2003 Dec; 38(4):357-67. PubMed ID: 14566856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ-specific susceptibility of p53 knockout mice to N-bis(2-hydroxypropyl)nitrosamine carcinogenesis.
    Hirata A; Tsukamoto T; Yamamoto M; Sakai H; Yanai T; Masegi T; Donehower LA; Tatematsu M
    Cancer Lett; 2006 Jul; 238(2):271-83. PubMed ID: 16150539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygous p53 knockout mouse model for dehydropyrrolizidine alkaloid-induced carcinogenesis.
    Brown AW; Stegelmeier BL; Colegate SM; Panter KE; Knoppel EL; Hall JO
    J Appl Toxicol; 2015 Dec; 35(12):1557-63. PubMed ID: 25690669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Kidney Injury Instigates Malignant Renal Cell Carcinoma via CXCR2 in Mice with Inactivated
    Zhou X; Xiao F; Sugimoto H; Li B; McAndrews KM; Kalluri R
    Cancer Res; 2021 May; 81(10):2690-2702. PubMed ID: 33558337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis.
    Trapasso F; Drusco A; Costinean S; Alder H; Aqeilan RI; Iuliano R; Gaudio E; Raso C; Zanesi N; Croce CM; Fusco A
    DNA Cell Biol; 2006 Jun; 25(6):376-82. PubMed ID: 16792508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidotal effect of grape juice (Vitis vinifera) on ochratoxin A caused hepatorenal carcinogenesis in mice (Mus musculus).
    Jeswal P
    Cytobios; 1998; 93(373):123-8. PubMed ID: 9734345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential Role of VHL, PTEN, and BAP1 Mutations in Renal Tumors.
    Szegedi K; Szabó Z; Kállai J; Király J; Szabó E; Bereczky Z; Juhász É; Dezső B; Szász C; Zsebik B; Flaskó T; Halmos G
    J Clin Med; 2023 Jul; 12(13):. PubMed ID: 37445575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of Serosal Vascular Proliferative Lesions to Hemangiosarcomas in the Uterus of the 26-Week Tg.rasH2 Mice Carcinogenicity Studies.
    Paranjpe MG; Belich JL; Richardson DR; Vidmar T; Mann PC; McKeon ME; Elbekai RH
    Int J Toxicol; 2017 Jan; 36(1):29-34. PubMed ID: 27440821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.